Literature DB >> 3185568

Accumulation of epidermal growth factor receptors in retinoic acid-treated fetal rat lung cells is due to enhanced receptor synthesis.

K C Oberg1, A M Soderquist, G Carpenter.   

Abstract

125I-Epidermal growth factor (EGF) binding capacity in fetal rat lung (FRL) cells is increased approximately 2 to 3-fold within 18 h of retinoic acid addition. Analysis of 125I-EGF binding assays at 0 C reveals approximately 25,000 receptors per cell, while analysis of growth factor binding to retinoic acid-treated cells demonstrates an increase in receptor levels to approximately 70,000 receptors per cell with no detectable changes in receptor affinities. We show by immunoprecipitation of 35S-methionine labeled EGF receptors that retinoic acid addition produces an increase in the accumulation of EGF receptor protein. Using brief pulses of 35S-methionine, an increase in EGF receptor synthesis can be identified within 3 h after retinoic acid addition. These results are the first to demonstrate that a retinoic acid-induced increase in 125I-EGF binding capacity is due to increased EGF receptor protein synthesis. Also, we find that a transient decrease in the rate of EGF receptor turnover occurs when retinoic acid is initially added to FRL cells. On the basis of our data, we conclude that the retinoic acid-induced accumulation of EGF receptors in FRL cells is primarily due to increased receptor synthesis. The effect of retinoic acid on EGF receptor turnover may be a secondary factor, influencing the rate at which receptors accumulate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3185568     DOI: 10.1210/mend-2-10-959

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  1 in total

1.  The proliferative effects of retinoic acid on primary cultures of adult rat type II pneumocytes depend upon cell density.

Authors:  Richard C Baybutt; Brendon W Smith; Elena V Donskaya; Ling Hu; Ting Li; Weiqun Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-09-29       Impact factor: 2.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.